Ann: Zelira Meets Primary Endpoints for Insomnia Trial, page-263

With any large projects and goals, you have to give them wiggle room otherwise you will spend far too much cost and time refining your estimates (and I'm sure someone would complain about that too) than what they are worth and here we are 3 business days past with a global pandemic and global shutdown.

I guess some people are hardline cookies if you want perfect pinning your investment on the difference of a few days/weeks you might want to leave now.

This trial did have a large number of secondary endpoints - far more than norm (from my searches), so with it being 3 days late at this stage in the current environment, while they also participated in the fronter data cannabis town hall. meh sounds ok to me at the moment nothing to complain about yet.

If no info this month ill just do the investment thing.. and call my 'employee' the CEO and ask... simple..